CD8A and common variable immunodeficiency: Finally, we studied changes longitudinally in various subsets of CD4, CD8, TFH, B cells, regulatory lymphocytes, and SARS-CoV-2-specific T cells prior to and following the 1st and 2nd doses of the SARS-CoV-2 vaccine in two HC and three patients with CVID.